northeast_georgia_medical_center_oncology_annual_r.pdf
NGMC Participates in Amgen DeLLphi-305 Drug Trial
Trusted by teams at
Description
NGMC offered the Amgen DeLLphi-305 trial to patients with extensive-stage small-cell lung cancer, providing access to the tarlatamab drug as part of a vendor-sponsored clinical study.
Contract Details
Vendor
AMGEN
Agency
Northeast Georgia Medical Center, Inc, GA
Contract Type
PROFESSIONAL_SERVICES
Document Date
January 1, 2024
More from AMGEN
Related Contracts
universities_of_wisconsin_board_of_regents_minutes.pdf
approvedcolumbia-state-community-college-board-of-trustees-minutes-fy2026-budget-opportunity-pointe-project-jun-26-2025_bf0.pdf
ongoinguniversity-of-wisconsin-stout-business-finance-committee-meeting-minutes-key-financials-clinical-trial-agreement-june-5-2025_e19.pdf
approveduw-system-board-of-regents-agenda-capital-planning-budget-business-finance-june-5-6-2025_253.pdf
NAuw_system_business_finance_committee_agenda_june_2.pdf
approvedIssuing Agency
Northeast Georgia Medical Center, Inc
Public Hospital
Gainesville, GA
More from Northeast Georgia Medical Center, Inc
northeast_georgia_community_health_needs_assessmen.pdf
northeast_georgia_regional_community_health_needs.pdf
northeast_georgia_regional_community_health_needs.pdf
northeast_georgia_community_health_needs_assessmen.pdf
northeast_georgia_medical_center_oncology_annual_r.pdf
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.